Frontier AI for human biology, starting with the brain.

The brain is the molecular ground truth for neurological disease, but it’s one of the hardest datasets to collect. Over a decade, we’ve built one of the world’s largest proprietary multi-modal neuroscience patient datasets of its kind: deep molecular profiling on 12,000+ brains, across 6,000 patients including paired proteomic, genomic, and clinical data. Plus a physical inventory of 900+ frozen brain tissue samples spanning the major neurodegenerative diseases.

We are building the first AI system designed to reason about neurological disease at the patient level. The output is a virtual biopsy of the brain — a reconstructed picture of what’s happening inside a patient’s brain, generated from a routine blood draw.

Our platform is solving the hardest problems in drug discovery — which targets to drug, in which patients — to increase the probability of clinical success. Drug developers can use our platform to power target discovery, target characterization, biomarker identification, and patient stratification — the full set of questions needed to design programs that work in humans.